Atlas Arteria Valuation
| MAQAF Stock | USD 3.41 0.08 2.29% |
At this time, the firm appears to be overvalued. Atlas Arteria Limited shows a prevailing Real Value of $2.87 per share. The current price of the firm is $3.41. Our model approximates the value of Atlas Arteria Limited from analyzing the firm fundamentals such as Return On Equity of 0.0695, profit margin of 2.33 %, and Current Valuation of 7.66 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Atlas Arteria's price fluctuation is risky at this time. Calculation of the real value of Atlas Arteria Limited is based on 3 months time horizon. Increasing Atlas Arteria's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Atlas Arteria Limited is useful when determining the fair value of the Atlas pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Atlas Arteria. Since Atlas Arteria is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Atlas Pink Sheet. However, Atlas Arteria's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.41 | Real 2.87 | Hype 3.41 |
The real value of Atlas Pink Sheet, also known as its intrinsic value, is the underlying worth of Atlas Arteria Limited Company, which is reflected in its stock price. It is based on Atlas Arteria's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Atlas Arteria's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Atlas Arteria's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Atlas Arteria Limited helps investors to forecast how Atlas pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Atlas Arteria more accurately as focusing exclusively on Atlas Arteria's fundamentals will not take into account other important factors: Atlas Arteria Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Atlas Arteria's current stock value. Our valuation model uses many indicators to compare Atlas Arteria value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atlas Arteria competition to find correlations between indicators driving Atlas Arteria's intrinsic value. More Info.Atlas Arteria Limited is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to book category among related companies fabricating about 0.10 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Atlas Arteria Limited is roughly 9.92 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Atlas Arteria by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Atlas Arteria's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Atlas Arteria's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Atlas Arteria's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Atlas Arteria and how it compares across the competition.
About Atlas Arteria Valuation
The pink sheet valuation mechanism determines the current worth of Atlas Arteria Limited on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Atlas Arteria Limited. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Atlas Arteria Limited based exclusively on its fundamental and basic technical indicators. By analyzing Atlas Arteria's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Atlas Arteria's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Atlas Arteria. We calculate exposure to Atlas Arteria's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Atlas Arteria's related companies.Atlas Arteria Limited owns, develops, and operates toll roads. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia. Macquarie Atlas operates under Infrastructure Operations classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Atlas Arteria's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Atlas Arteria's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Atlas Arteria's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Atlas Arteria's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Atlas Arteria's revenue streams: Identify Atlas Arteria's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Atlas Arteria's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Atlas Arteria's growth potential: Evaluate Atlas Arteria's management, business model, and growth potential.
- Determine Atlas Arteria's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Atlas Arteria's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Atlas Arteria represents a small ownership stake in the entity. As a stockholder of Atlas, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Atlas Arteria Dividends Analysis For Valuation
Please note that Atlas Arteria has scaled down on payment of dividends at this time.
There are various types of dividends Atlas Arteria can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Atlas shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Atlas Arteria Limited directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Atlas pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Atlas Arteria by the value of the dividends paid out.
Atlas Arteria Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Atlas Arteria does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1 B | |
| Quarterly Earnings Growth Y O Y | 1.558 | |
| Forward Price Earnings | 32.6797 | |
| Retained Earnings | -439.1 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Atlas Arteria Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Atlas Arteria Limited information on this page should be used as a complementary analysis to other Atlas Arteria's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Atlas Pink Sheet analysis
When running Atlas Arteria's price analysis, check to measure Atlas Arteria's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atlas Arteria is operating at the current time. Most of Atlas Arteria's value examination focuses on studying past and present price action to predict the probability of Atlas Arteria's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atlas Arteria's price. Additionally, you may evaluate how the addition of Atlas Arteria to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |